Innoviva (INVA) Operating Expenses (2010 - 2026)

Innoviva has reported Operating Expenses for 17 years, with the latest figure at $37.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 18.16% year-over-year to $37.7 million; the trailing twelve-month figure through Mar 2026 stood at $113.0 million (up 22.92% YoY), and the FY2025 full-year result was $143.9 million, up 11.27% from the prior year.
• Operating Expenses for Q1 2026 stood at $37.7 million, down from $41.0 million in the prior quarter.
• The five-year high for Operating Expenses was $87.7 million in Q2 2022, with the low at -$219.2 million in Q3 2022.
• Historically, Operating Expenses has averaged $18.8 million across 5 years, with a median of $34.4 million in 2025.
• The largest YoY upside for Operating Expenses was 1956.38% in 2022 against a maximum downside of 765.76% in 2022.
• Innoviva's Operating Expenses stood at -$219.2 million in 2022, then soared by 91.47% to -$18.7 million in 2023, then jumped by 259.26% to $29.8 million in 2024, then jumped by 37.59% to $41.0 million in 2025, then dropped by 8.01% to $37.7 million in 2026.
• The last three Operating Expenses figures came in at $37.7 million (Q1 2026), $41.0 million (Q3 2025), and $34.4 million (Q2 2025), per Business Quant data.